Encompass Health Reports Strong Q2 2025 Financial Results

Encompass Health ( (EHC) ) just unveiled an announcement.

Encompass Health reported its financial results for the second quarter of 2025, showing a 12% increase in net operating revenue compared to the previous year, driven by a 7.2% growth in total discharges and a 4.2% increase in net patient revenue per discharge. The company also reported a 24.3% increase in cash flows from operating activities and a 17.2% rise in Adjusted EBITDA, reflecting improved revenue and expense leverage. Additionally, Encompass Health increased its full-year guidance for 2025, indicating strong operational performance and future growth prospects.

The most recent analyst rating on (EHC) stock is a Buy with a $105.00 price target. To see the full list of analyst forecasts on Encompass Health stock, see the EHC Stock Forecast page.

Spark’s Take on EHC Stock

According to Spark, TipRanks’ AI Analyst, EHC is a Neutral.

Encompass Health’s overall stock score of 65 is driven by strong financial performance and positive earnings call sentiment, indicating growth potential and operational efficiency. However, technical analysis reveals bearish signals, and valuation metrics suggest the stock may be relatively expensive. The company’s strategic expansion and improved cash flow contribute positively to the outlook, but market momentum remains a concern.

To see Spark’s full report on EHC stock, click here.

More about Encompass Health

Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the United States, with a presence in 38 states and Puerto Rico. The company focuses on providing high-quality rehabilitative care for patients recovering from major injuries or illnesses, utilizing advanced technology and innovative treatments to maximize recovery.

Average Trading Volume: 814,312

Technical Sentiment Signal: Buy

Current Market Cap: $10.94B

For detailed information about EHC stock, go to TipRanks’ Stock Analysis page.